Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Swiss Exchange  >  Lonza Group    LONN   CH0013841017

LONZA GROUP

(LONN)
  Report  
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Swiss Exchange
05/14/2019 05/15/2019 05/16/2019 05/17/2019 05/20/2019 Date
309.8(c) 313.4(c) 319(c) 317.2(c) 310.4 Last
251 971 218 201 232 342 159 726 118 550 Volume
+1.31% +1.16% +1.79% -0.56% -2.14% Change
More quotes
Financials (CHF)
Sales 2019 5 921 M
EBIT 2019 1 170 M
Net income 2019 808 M
Debt 2019 2 924 M
Yield 2019 0,91%
Sales 2020 6 323 M
EBIT 2020 1 309 M
Net income 2020 929 M
Debt 2020 2 471 M
Yield 2020 0,99%
P/E ratio 2019 28,52
P/E ratio 2020 25,67
EV / Sales2019 4,48x
EV / Sales2020 4,13x
Capitalization 23 621 M
More Financials
Company
Lonza Group is one of the world leaders of the development, production and marketing of chemical products. Net sales break down by family of products and services as follows: - fine organic and performance chemical products (54.9%): for food products, hygiene products, beauty products, water... 
More about the company
Surperformance© ratings of Lonza Group
Trading Rating : Investor Rating :
More Ratings
Latest news on LONZA GROUP
05/18LONZA : Defense Logistics Agency Energy Aerospace Energy awarded $8m contract fo..
AQ
05/14LONZA : Chiasma and Lonza Announce Progression of Oral Octreotide Capsules Devel..
AQ
05/08LONZA : Showcases New SYNETH Product Range of Polyglycerol Esters for Perfect Ba..
AQ
05/07LONZA : Showcases New SYNETH™ Product Range of Polyglycerol Esters for Per..
PU
05/07LONZA : Highlights H2OBioEV™ Bioactive Functional for Skin Rejuvenation at..
PU
05/07LONZA : Previews its Newest Clean Label Innovation - Vcaps plus White Opal, a Ti..
AQ
05/06LONZA : Previews its Newest Clean Label Innovation – Vcaps ® Plus White Op..
PU
05/02LONZA : Alector Opts for Lonza's Ibex™ Develop to Secure Future Manufactur..
PU
05/01LONZA : Launches SimpliFiH Services an Integrated First-in-Human Service Package..
AQ
04/30LONZA : Launches SimpliFiH™ Services – an Integrated First-in-Human ..
PU
More news
Analyst Recommendations on LONZA GROUP
More recommendations
Sector news : Biotechnology & Medical Research - NEC
05/15GILEAD SCIENCES : Novartis gets approval to sell Kymriah in Japan for $306,000
RE
05/13REGENERON PHARMACEUTICALS : Says FDA Approves Eylea Injection for All Diabetic R..
DJ
05/10PATRICK THOMAS : Biotech Industry Woos Talent With Top Pay -- WSJ
DJ
05/09PATRICK THOMAS : Biotech Is Place to Be for Top Salaries
DJ
05/08GLOBAL MARKETS LIVE : Siemens, Airbus, Nestlé, Tesla…
More sector news : Biotechnology & Medical Research - NEC
Chart LONZA GROUP
Duration : Period :
Lonza Group Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends LONZA GROUP
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 13
Average target price 333  CHF
Spread / Average Target 4,9%
EPS Revisions
Managers
NameTitle
Richard Ridinger Chief Executive Officer
Albert M. Baehny Chairman
Rodolfo Savitzky Chief Financial Officer
Patrick Aebischer Vice Chairman
Margot A. Scheltema Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
LONZA GROUP24.54%23 366
IQVIA HOLDINGS INC15.06%26 365
CELLTRION, INC.--.--%21 024
INCYTE CORPORATION21.40%16 555
EXACT SCIENCES CORPORATION52.44%12 422
SEATTLE GENETICS, INC.17.23%10 715